QLIFE Share Price Performance
SEK 4.13
1.27 (44.41%)
Price SEK 4.13
Share PriceSEK 4.13
QLIFE Community Narratives
There are no narratives available yet.
Recent QLIFE News & Updates
Qlife Holding AB (publ) Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 27, 2025
- Earnings per share (EPS)
- -2.82
- Gross Margin
- -28.75%
- Net Profit Margin
- -22,000.63%
- Debt/Equity Ratio
- -2,370.3%
Qlife Holding AB (publ) Competitors
Snowflake Analysis
About QLIFE
- Founded
- 2019
- Employees
- 1
- CEO
- WebsiteView website
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testing, consisting of a small device, disposable capsules, and the supplementing software. Its biomarkers include CRP/C-reactive protein, procalcitonin, Nt-pro-BNP, lipids, HbA1c/D-vitami, and D-dimer. Qlife Holding AB (publ) was incorporated in 2019 and is based in Helsingborg, Sweden.
Market Insight
Market sentiment on BTC treasury companies is moving, and with volatility rising, disagreements over their future prospects are as heated as ever.
Continue reading
Swedish Market Performance
- 7 Days: 2.2%
- 3 Months: 5.1%
- 1 Year: 0.6%
- Year to Date: 3.5%
Over the last 7 days, the market has risen 2.2%, driven by gains in every sector, especially the Industrials sector. In the last 12 months, the market has been flat. As for the next few years, earnings are expected to grow by 17% per annum. Market details ›